Specialty PACS Market Is Projected to Reach an Estimate of $4,485.96 Million By 2030, Claims Allied Market Research

Allied Market Research

The global specialty PACS market growth is driven by the rise in investments in medical imaging, increasing utilization of imaging equipment, and the rise in the geriatric population.

Wilmington, Delaware, Oct. 25, 2023 (GLOBE NEWSWIRE) -- According to the report released by Allied Market Research, titled, Specialty PACS Market by Type (Women's Health PACS, Orthopedics PACS, Radiology PACS, Pathology PACS, Oncology PACS, Endoscopy PACS), by Deployment Model (Cloud-Based Specialty PACS and On-Premises Specialty PACS), by End User (Ambulatory Surgical Centers, Hospitals and Clinics, and Others): Global Opportunity Analysis and Industry Forecast, 2021–2030.” As per the report, the global specialty PACS industry was estimated at $2,682.88 million in 2020 and is estimated to reach $4,485.96 million by 2030, growing at a CAGR of 5.5% from 2021 to 2030. 

Request Sample of the Report on Specialty PACS Market Forecast 2032 -   https://www.alliedmarketresearch.com/request-sample/10827

Prime Drivers of Growth:

The global specialty PACS market growth is driven by the rise in investments in medical imaging, increasing usage of imaging systems, and the rise in the geriatric populace. On the other hand, the increasing cost of remedy and a lack of awareness of the technology impede market growth to some extent. Moreover, the improvement of imaging solutions is anticipated to offer the market players new opportunities in the future.

The radiology PACS segment to maintain its leadership status throughout the forecast period-

By type, the radiology PACS segment held the major share in 2020, holding nearly three-fifths of the global specialty PACS market revenue, and is expected to maintain its leadership status throughout the projection period. This is due to a growing geriatric population, as well as an increase in the volume of medical imaging. However, the ophthalmology PACS segment would display the fastest CAGR of 6.2% from 2021 to 2030. This is due to the increasing incidence of chronic illnesses and the surge in demand for medical imaging services.

Recent Developments in the Specialty PACS Market 

  • In April 2022, FUJIFILM Healthcare Americas Corporation, a one of the leading provider of enterprise imaging and informatics solutions, has installed Fujifilm’s Synapse Cardiology PACS version 7 throughout Emory Healthcare facilities to store, process and analyze heart and vascular imaging. Emory Healthcare is the most comprehensive academic health system in Georgia.

  • In March 2022, InteleradMedical Systems launched its new Enterprise Imaging and Informatics Suite at the 2022 HIMSS Global Health Conference & Exhibition in Orlando, Florida. This suite include IntelePACS is developed to empower hospitals and health systems to break down siloed data and create a seamless, vendor-neutral information hub, integrating vital patient data across the entire healthcare ecosystem.

  • In December 2021, Synapsica, one of the India’s leading AI-based radiology reporting company announced a partnership with GenWorks Health, a healthcare options supplier backed by Wipro GE Healthcare, to deliver its PACS to cities across India. Its Radiolens radiology workflow resolution routinely detects dangerous high-quality scans and creates preliminary studies for most typical modalities.

  • In November 2020, Siemens Healthineers introduced Syngo Carbon, a new software environment for enterprise-wide image reading and reporting. With Syngo Carbon1, Siemens Healthineers assures easy access to all relevant data generated in the processes of imaging and reporting.

  • In November 2020, INFINITT North America participated in the RSNA’s virtual meeting where it announced the launch of its PACS products like INFINITT PACS 7.0, INFINITT’s Mammo PACS, INFINITT Digital Pathology PACS and INFINITT RT PACS.